/NIRV.CN
NIRV.CN Stock - Nirvana Life Sciences Inc.
Healthcare|BiotechnologyCNQ
$0.07+16.67%
+$0.01 (+16.67%) • Dec 19
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NIRV.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.07 – $0.07
TARGET (TP)$0.08
STOP LOSS$0.06
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.07
52W High$0.50
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-339,944 | $-1,175.458 | $-859,121 | $-314,239 | $-74,533 |
| Net Income | $-365,918 | $-1,487.302 | $-5,654,205 | $-314,239 | $13,307 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.08 | $-0.00 | $-0.15 | $-0.01 | $0.00 |
Company Overview
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds; and the improvement of propagation techniques for growing such biomass on a large scale. The company was incorporated in 2020 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NIRV.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2023
EPS Surprise History
Q3 20
No data
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q1 22
No data
Q3 22
No data
Q4 22
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Oct 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.00 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 30, 2021 | — | $0.00 | — | — |
Q1 2021 | Jan 31, 2021 | — | $-0.00 | — | — |
Q3 2020 | Jul 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Jan 31, 2020 | — | $-0.00 | — | — |
Q3 2019 | Jul 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Apr 30, 2019 | — | $-0.00 | — | — |
Q1 2019 | Jan 31, 2019 | — | $-0.00 | — | — |
Q3 2018 | Jul 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Apr 30, 2018 | — | $-0.00 | — | — |
Q1 2018 | Jan 31, 2018 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NIRV.CN
What is NIRV.CN's current stock price?
Nirvana Life Sciences Inc. (NIRV.CN) is currently trading at $0.07 per share. The stock has moved +16.67% today.
What is the analyst price target for NIRV.CN?
No analyst price targets are currently available for this stock.
What sector is Nirvana Life Sciences Inc. in?
Nirvana Life Sciences Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.
What is NIRV.CN's market cap?
Nirvana Life Sciences Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NIRV.CN pay dividends?
No, Nirvana Life Sciences Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABRT.CN
Albert Labs International Corp.
$0.01
Mkt Cap: $0.0B
ASTI.CN
Aquarius Surgical Technologies Inc.
$0.01
Mkt Cap: $0.0B
BTI.V
Bioasis Technologies Inc.
$0.01
Mkt Cap: $0.0B
CHGX.CN
ChitogenX Inc.
$0.01
Mkt Cap: $0.0B
CURE.CN
Biocure Technology Inc.
$0.01
Mkt Cap: $0.0B
HEAL.CN
Restart Life Sciences Corp.
$0.11
Mkt Cap: $0.0B
LOWL.CN
Lowell Farms Inc.
$0.01
Mkt Cap: $0.0B
NSHS.CN
NanoSphere Health Sciences Inc.
$0.03
Mkt Cap: $0.0B
PLCN.CN
Cannibble Food-Tech Ltd.
$0.01
Mkt Cap: $0.0B
WBIO.CN
WPD Pharmaceuticals Inc.
$0.07
Mkt Cap: $0.0B
Explore stocks similar to NIRV.CN for comparison